Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD
dc.contributor.author | Shroff R. | |
dc.contributor.author | Aitkenhead H. | |
dc.contributor.author | Costa N. | |
dc.contributor.author | Trivelli A. | |
dc.contributor.author | Litwin M. | |
dc.contributor.author | Picca S. | |
dc.contributor.author | Anarat A. | |
dc.contributor.author | Sallay P. | |
dc.contributor.author | Ozaltin F. | |
dc.contributor.author | Zurowska A. | |
dc.contributor.author | Jankauskiene A. | |
dc.contributor.author | Montini G. | |
dc.contributor.author | Charbit M. | |
dc.contributor.author | Schaefer F. | |
dc.contributor.author | Wühl E. | |
dc.contributor.author | Bakkaloglu A. | |
dc.contributor.author | Peco-Antic A. | |
dc.contributor.author | Querfeld U. | |
dc.contributor.author | Gellermann J. | |
dc.contributor.author | Drozdz D. | |
dc.contributor.author | Bonzel K.-E. | |
dc.contributor.author | Wingen A.-M. | |
dc.contributor.author | Balasz I. | |
dc.contributor.author | Perfumo F. | |
dc.contributor.author | Müller-Wiefel D.E. | |
dc.contributor.author | Möller K. | |
dc.contributor.author | Offner G. | |
dc.contributor.author | Enke B. | |
dc.contributor.author | Gimpel C. | |
dc.contributor.author | Mehls O. | |
dc.contributor.author | Emre S. | |
dc.contributor.author | Caliskan S. | |
dc.contributor.author | Mir S. | |
dc.contributor.author | Wygoda S. | |
dc.contributor.author | Hohbach-Hohenfellner K. | |
dc.contributor.author | Jeck N. | |
dc.contributor.author | Klaus G. | |
dc.contributor.author | Ardissino G. | |
dc.contributor.author | Testa S. | |
dc.contributor.author | Niaudet P. | |
dc.contributor.author | Caldas-Afonso A. | |
dc.contributor.author | Fernandes-Teixeira A. | |
dc.contributor.author | Duek J. | |
dc.contributor.author | Matteucci M.C. | |
dc.contributor.author | Mastrostefano A. | |
dc.contributor.author | Wigger M. | |
dc.contributor.author | Berg U.B. | |
dc.contributor.author | Celsi G. | |
dc.contributor.author | Fischbach M. | |
dc.contributor.author | Terzic J. | |
dc.contributor.author | Fydryk J. | |
dc.contributor.author | Urasinski T. | |
dc.contributor.author | Coppo R. | |
dc.contributor.author | Peruzzi L. | |
dc.contributor.author | Arbeiter K. | |
dc.contributor.author | Jankauskiené A. | |
dc.contributor.author | Grenda R. | |
dc.contributor.author | Janas R. | |
dc.contributor.author | Laube G. | |
dc.contributor.author | Neuhaus T.J. | |
dc.date.accessioned | 2019-10-26T21:20:09Z | |
dc.date.available | 2019-10-26T21:20:09Z | |
dc.date.issued | 2016 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Angiotensin-converting enzyme inhibitors (ACEi) for renin-angiotensin-aldosterone system (RAAS) blockade are routinely used to slow CKD progression. However, Vitamin D may also promote renoprotection by suppressing renin transcription through cross-talk between RAAS and Vitamin D -fibroblast growth factor-23 (FGF-23)-Klotho pathways. To determine whether Vitamin D levels influence proteinuria and CKD progression in children, we performed a post hoc analysis of the Effect of Strict Blood Pressure Control and ACE Inhibition on Progression of CKD in Pediatric Patients (ESCAPE) cohort. In 167 children (median EGFR 51 ml/min per 1.73 m2), serum 25-hydroxyvitaminD(25(OH)D),FGF-23, andKlotho levelsweremeasuredatbaselineandafteramedian8months onACEi.Childrenwith lower 25(OH)D levels had higher urinary protein/creatinine ratios at baseline (P=0.03) and at follow-up (P=0.006). Levels of 25(OH)D and serum Vitamin D -binding protein were not associated, but 25(OH)D #50 nmol/L associated with higher diastolicBP(P=0.004).ACEi therapy alsoassociatedwith increasedKlotho levels (P<0.001). The annualized loss of EGFR was inversely associated with baseline 25(OH)D level (P<0.001, r=0.32). Five-year renal survivalwas 75%in patientswith baseline 25(OH)D$50 nmol/L and 50%in thosewith lower 25(OH) D levels (P<0.001). This renoprotective effect remained significant but attenuated with ACEi therapy (P=0.05). Renal survival increased 8.2% per 10 nmol/L increase in 25(OH)D (P=0.03), independent of EGFR; proteinuria, BP, and FGF-23 levels; and underlying renal diagnosis. In children with CKD, 25(OH)D?50 nmol/L was associatedwith greater preservation of renal function. This effect was present but attenuated with concomitant ACEi therapy. © 2016 by the American Society of Nephrology. | en_US |
dc.identifier.doi | 10.1681/ASN.2014090947 | en_US |
dc.identifier.endpage | 322 | en_US |
dc.identifier.issn | 1046-6673 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 26069294 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 314 | en_US |
dc.identifier.uri | https://doi.org/10.1681/ASN.2014090947 | |
dc.identifier.uri | https://hdl.handle.net/11454/16734 | |
dc.identifier.volume | 27 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Society of Nephrology | en_US |
dc.relation.ispartof | Journal of the American Society of Nephrology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD | en_US |
dc.type | Article | en_US |